Sonnet BioTherapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative) - shares		1 Months Ended			3 Months Ended
Subsequent Events (Details Narrative) - shares	Sep. 30, 2015	Oct. 31, 2015	Sep. 30, 2015	Jan. 31, 2015	Sep. 30, 2015
Number of shares issued for the conversion of a convertible note payable	500,000		168,713	373,333	289,176
Subsequent Event [Member] \| Convertible Promissory Note [Member]
Number of shares issued for the conversion of a convertible note payable		1,400,000